Currently, short interest accounts for more than half of the stock's total available float. At AEGR's average daily volumes, it would take more than 12 days for bears to cover these positions. And options traders have been pessimistic, too. On …
Aegerion Pharmaceuticals, Inc. AEGR is expected to report fourth-quarter 2015 and full ... show that Aegerion is likely to beat estimates this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 …
One name in particular that got drilled viciously was Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR). The company posted a huge earnings miss and offered less than stellar guidance. To make things worse, the company’s stock was …
AEGR) announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange …
Investors who purchased shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) prior to April 2013 and continue to …
Aegerion Pharmaceuticals Inc. (AEGR) announced after the close Tuesday that JUXTAPID has been approved by Japan's Ministry of Health, Labor & Welfare for the treatment of homozygous familial hypercholesterolemia. The stock is now up …
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that …
New York, NY - (ACCESSWIRE) - 10/30/2013 - Equity Profile Report initiates its NASDAQ Active Stock Weekly Watch List adding SodaStream International Ltd. (NASDAQ:SODA - News), Merrimack Pharmaceuticals, Inc. …
Four months after restructuring the ailing Aegerion ($AEGR) and axing about 80 staffers ... named Novelion that leaves the QLT shareholders with the lion’s share of the stock and Szela with the helm. An investment syndicate led by Deerfield …
MacFall, announces that a complaint has been filed in the United States District Court for the District of Massachusetts …